Nowadays, we have a paradigm shift in cancer treatment that targets the immune system rather than the tumor.
In this symposium, expert scientists will present basic concept of next generation immunotherapy for cancer, and provide educational contents for young scientists as well as clinical application for medical oncologists.
This symposium will facilitate important dialogues on the latest advances in tumor immunology/immunotherapy and offer robust opportunities for international networking and interaction.

Yutaka Kawakami, MD, PhD
(Institute of Advanced Medical Research, Keio University)
Tsukasa Seya, MD, PhD
(Department of Vaccine Immunology, Hokkaido University)
Toshihiko Torigoe, MD, PhD
(Department of Pathology, Sapporo Medical University)